Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76eb42c17e4a0eb9fb4c17151754b201 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
filingDate |
2008-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d94070a14bbd764e69c7e64b161d2f6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37506181229781757523fb548b4bfb85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac6b025fcf9717455d1a6140019ac80 |
publicationDate |
2009-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2728539-A1 |
titleOfInvention |
Pharmaceutical compositions of rosuvastatin calcium |
abstract |
This invention is related to pharmaceutical compositions of rosuvastatin or pharmaceutically acceptable salts thereof especially calcium salt with sodium carbonate anhydrous which has effects on dissoltion profiles in 0.1 N HCI medium provided that using of sodium carbonate anhydrous should be presence in the range of from about 0,5 % to about 2 % by weight. |
priorityDate |
2008-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |